Clinical Trial: The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264283) titled 'The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31' on Nov. 24.

Brief Summary: The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: PSP - Progressive Supranuclear Palsy

Intervention: DRUG: LM11A-31

LM11A-31 is administered orally twice daily.

DRUG: Matching Placebo

Matching placeb...